...
首页> 外文期刊>Cancer Cell International >ZIP8 expression in human proximal tubule cells, human urothelial cells transformed by Cd +2 and As +3 and in specimens of normal human urothelium and urothelial cancer
【24h】

ZIP8 expression in human proximal tubule cells, human urothelial cells transformed by Cd +2 and As +3 and in specimens of normal human urothelium and urothelial cancer

机译:ZIP8在人近端肾小管细胞,Cd +2和As +3转化的人尿道上皮细胞以及正常人尿道上皮和尿路上皮癌标本中的表达

获取原文
           

摘要

ZIP8 functions endogenously as a Zn+2/HCO3- symporter that can also bring cadmium (Cd+2) into the cell. It has also been proposed that ZIP8 participates in Cd-induced testicular necrosis and renal disease. In this study real-time PCR, western analysis, immunostaining and fluorescent localization were used to define the expression of ZIP8 in human kidney, cultured human proximal tubule (HPT) cells, normal and malignant human urothelium and Cd+2 and arsenite (As+3) transformed urothelial cells. It was shown that in the renal system both the non-glycosylated and glycosylated form of ZIP8 was expressed in the proximal tubule cells with localization of ZIP8 to the cytoplasm and cell membrane; findings in line with previous studies on ZIP8. The studies in the bladder were the first to show that ZIP8 was expressed in normal urothelium and that ZIP8 could be localized to the paranuclear region. Studies in the UROtsa cell line confirmed a paranuclear localization of ZIP8, however addition of growth medium to the cells increased the expression of the protein in the UROtsa cells. In archival human samples of the normal urothelium, the expression of ZIP8 was variable in intensity whereas in urothelial cancers ZIP8 was expressed in 13 of 14 samples, with one high grade invasive urothelial cancer showing no expression. The expression of ZIP8 was similar in the Cd+2 and As+3 transformed UROtsa cell lines and their tumor transplants. This is the first study which shows that ZIP8 is expressed in the normal urothelium and in bladder cancer. In addition the normal UROtsa cell line and its transformed counterparts show similar expression of ZIP8 compared to the normal urothelium and the urothelial cancers suggesting that the UROtsa cell line could serve as a model system to study the expression of ZIP8 in bladder disease.
机译:ZIP8作为Zn + 2 / HCO3-的内源转运子,也可将镉(Cd + 2)引入细胞。还提出ZIP8参与Cd诱导的睾丸坏死和肾脏疾病。在这项研究中,采用实时PCR,蛋白质印迹分析,免疫染色和荧光定位来定义ZIP8在人肾,培养的人近端肾小管(HPT)细胞,正常和恶性人尿路上皮以及Cd + 2和亚砷酸盐(As + 3)转化的尿路上皮细胞。结果表明,在肾脏系统中,ZIP8的非糖基化和糖基化形式均在近端小管细胞中表达,并且ZIP8定位于细胞质和细胞膜。研究结果与先前对ZIP8的研究一致。膀胱癌研究首次表明ZIP8在正常尿路上皮中表达,并且ZIP8可能位于核旁区域。在UROtsa细胞系中的研究证实了ZIP8的核旁定位,但是向细胞中添加生长培养基会增加UROtsa细胞中蛋白质的表达。在正常尿路上皮的存档人样本中,ZIP8的表达强度是可变的,而在尿路上皮癌中,ZIP8在14个样本中的13个样本中表达,其中一种高浸润性尿路上皮癌未表达。 ZIP8在Cd + 2和As + 3转化的UROtsa细胞系及其肿瘤移植物中的表达相似。这是第一项显示ZIP8在正常尿路上皮和膀胱癌中表达的研究。此外,正常的UROTsa细胞系及其转化的对应物与正常的尿路上皮和尿路上皮癌相比,显示ZIP8的表达相似,这表明UROTtsa细胞系可以用作研究ZIP8在膀胱疾病中表​​达的模型系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号